Status:
UNKNOWN
H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection
Lead Sponsor:
Korean College of Helicobacter and Upper Gastrointestinal Research
Conditions:
Ulcer
Eligibility:
All Genders
30-75 years
Phase:
PHASE4
Brief Summary
This study will evaluate the effect of Helicobacter pylori eradication therapy on the healing of iatrogenic gastric ulcer caused by endoscopic mucosal resection of gastric neoplastic lesions and is a ...
Eligibility Criteria
Inclusion
- 30 - 75 years old
- Early gastric cancer (\< 3 cm in size, mucosa confined, differentiated type) or gastric adenoma (\< 3 cm in size)
- Helicobacter pylori positive
Exclusion
- Medication of anti-secretory drugs (proton pump inhibitors, H2-receptor antagonists, antacid, bismuth compound)
- History of Helicobacter pylori eradication
- History of gastric surgery or other cancers
- Major comorbidities
- Medication of ASA, NSAIDS, steroids, anti-coagulants
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
232 Patients enrolled
Trial Details
Trial ID
NCT00926809
Start Date
September 1 2008
End Date
December 1 2010
Last Update
June 25 2009
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center Korea
Goyang, South Korea
2
Asan Medical Center
Seoul, South Korea
3
Korea University Hospital
Seoul, South Korea
4
Seoul National University Hospital
Seoul, South Korea